A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer

Author： Jeung Hei-Cheul   Rha Sun   Noh Sung   Roh Jae   Chung Hyun  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.59, Iss.3, 2007-03, pp. : 313-320

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer

By Kim Jong   Sohn Sang   Song Hong   Kwon Ki-Young   Do Young   Lee Kyung   Hyun Myung   Ryoo Hun   Bae Sung   Park Keon   Baek Jin   Lee Won   Chung Joo   Cho Goon   Sohn Chang-Hak   Jang Jung   Chung Ho   Yu Wansik  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 6, 2007-11 ,pp. : 863-869

Springer Publishing Company

Access to resources Recommend Favorite

Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group

By Comella Pasquale   Lorusso Vito   Maiorino Luigi   Casaretti Rossana   Cannone Michele   Massidda Bruno   Putzu Carlo   Leo Silvana   Roselli Mario   Mancarella Sergio   Palmeri Sergio   Greco Ettore   Vessia Giacomo   Sandomenico Claudia   Franco Luca  

Cancer Chemotherapy and Pharmacology, Vol. 64, Iss. 5, 2009-10 ,pp. : 893-899

Springer Publishing Company

Access to resources Recommend Favorite

Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial

By Gubanski Michael   Johnsson Anders   Fernebro Eva   Kadar Lianna   Karlberg Ingegerd   Flygare Petra   Berglund Åke   Glimelius Bengt   Lind Pehr  

Gastric Cancer, Vol. 13, Iss. 3, 2010-08 ,pp. : 155-161

Springer Publishing Company

Access to resources Recommend Favorite

Phase I trial of weekly irinotecan combined with UFT as second-line treatment for advanced colorectal cancer

By Alonso V.   Escudero P.   Zorrilla M.   Isla M.D.   Herrero A.   Mayordomo J.I.   Martinez-Trufero J.   Saenz A.   Tres A.   Anton A.  

European Journal of Cancer, Vol. 37, Iss. 18, 2001-12 ,pp. : 2385-2391

Elsevier

Access to resources Recommend Favorite

A randomized phase II study comparing S-1 plus weekly split-dose cisplatin with S-1 plus standard-dose cisplatin as first-line chemotherapy for advanced gastric cancer

By Moriwaki Toshikazu   Hirai Shinji   Hironaka Shuichi   Amagai Kenji   Soeda Atsuko   Sato Mikio   Nihei Takeshi   Hirose Mitsuaki   Matsuda Kenji   Ohkawara Atsushi   Yamaguchi Taketo   Ozeki Mitsuharu   Mamiya Takashi   Murashita Tetsuya   Hyodo Ichinosuke  

Gastric Cancer, Vol. 17, Iss. 2, 2014-04 ,pp. : 354-361

Springer Publishing Company

Access to resources Recommend Favorite